Rapid Diagnostic for HCMV Serological Status
$224,887N43FY2017AINIH
Nanocomposix, Inc., San Diego CA
Investigators
Abstract
To develop a point-of-care diagnostic to detect the presence of IgG and IgM antibodies against human cytomegalovirus (HCMV)
View original record on NIH RePORTER →